Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 1
2009 2
2010 1
2011 3
2012 2
2013 5
2014 7
2015 4
2016 1
2020 4
2021 10
2022 6
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean peyman (1,205 results)?
Ginsenoside Rd: A promising natural neuroprotective agent.
Chen YY, Liu QP, An P, Jia M, Luan X, Tang JY, Zhang H. Chen YY, et al. Among authors: an p. Phytomedicine. 2022 Jan;95:153883. doi: 10.1016/j.phymed.2021.153883. Epub 2021 Dec 8. Phytomedicine. 2022. PMID: 34952508 Review.
Forsythiasides: A review of the pharmacological effects.
Yang HX, Liu QP, Zhou YX, Chen YY, An P, Xing YZ, Zhang L, Jia M, Zhang H. Yang HX, et al. Among authors: an p. Front Cardiovasc Med. 2022 Jul 25;9:971491. doi: 10.3389/fcvm.2022.971491. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35958429 Free PMC article. Review.
Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
Zhang B, Cheng Z, Chen J, Zhang X, Liu D, Jiang H, Ma G, Wang X, Gan S, Sun J, Jin P, Yi J, Shi B, Ma J, Ye S, Wang G, Ji L, Gu X, Yu T, An P, Deng H, Li H, Li L, Ma Q, Qian L, Yang W. Zhang B, et al. Among authors: an p. Diabetes Care. 2024 Jan 1;47(1):160-168. doi: 10.2337/dc23-1287. Diabetes Care. 2024. PMID: 37943529 Free PMC article. Clinical Trial.
Cinobufagin: a promising therapeutic agent for cancer.
Dai CL, Zhang RJ, An P, Deng YQ, Rahman K, Zhang H. Dai CL, et al. Among authors: an p. J Pharm Pharmacol. 2023 Sep 1;75(9):1141-1153. doi: 10.1093/jpp/rgad059. J Pharm Pharmacol. 2023. PMID: 37390473 Review.
IBI362 (LY3305677), a weekly-dose GLP-1 and glucagon receptor dual agonist, in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple ascending dose phase 1b study.
Ji L, Jiang H, An P, Deng H, Liu M, Li L, Feng L, Song B, Han-Zhang H, Ma Q, Qian L. Ji L, et al. Among authors: an p. EClinicalMedicine. 2021 Aug 13;39:101088. doi: 10.1016/j.eclinm.2021.101088. eCollection 2021 Sep. EClinicalMedicine. 2021. PMID: 34430840 Free PMC article.
Efficacy and safety of tafolecimab in Chinese patients with heterozygous familial hypercholesterolemia: a randomized, double-blind, placebo-controlled phase 3 trial (CREDIT-2).
Chai M, He Y, Zhao W, Han X, Zhao G, Ma X, Qiao P, Shi D, Liu Y, Han W, An P, Li H, Yan S, Ma Q, Deng H, Qian L, Zhou Y; CREDIT-2 investigators. Chai M, et al. Among authors: an p. BMC Med. 2023 Feb 28;21(1):77. doi: 10.1186/s12916-023-02797-8. BMC Med. 2023. PMID: 36855099 Free PMC article. Clinical Trial.
55 results